Plenary Discussion. The Eurasian Pharma Market: The Industry's View on Challenges and Prospects
EAEU Pharma Market: Growth, Barriers, Prospects
Production Localization: Incentives, Challenges, Success Stories
The Impact of Regulatory Requirements on Business Strategies
Liberalization of Public Procurement: New Opportunities for Business
Moderator: VYACHESLAV LOKSHIN
President, Association of International Pharmaceutical Manufacturers in the Republic of Kazakhstan
SOFIA YATSKO
Deputy Director for Public Relations and Market Access, GEROPHARM
ELENA LEE
Founder, Dolce Group, President of AIID
ADILET NAZARBAYEV
General Director, Johnson & Johnson Kazakhstan
ZAITUNA SALMANOVA
Operations Director of Business Processes in the CauCAR region, Pfizer
OLZHAS SATYBALDIN
Head of Government Relations, Russia and Eurasia, AstraZeneca
PAVEL KHEGAY
General Director, Gedeon Richter Kazakhstan, Chairman of the Health Committee, EUROBAK
10:30 – 11:00
10:30 – 11:00
Coffee Break & Networking
11:00 – 12:20
11:00 – 12:20
Plenary Session. State and Business: Creating Conditions for Industry Development
Legislative Changes: New Registration Rules, GMP Inspections, Clinical Trials
Harmonization of Requirements in the EAEU: Progress and Next Steps
Support for Localization and Innovation: Government Incentive Measures
Plans for Improving the Investment Climate in the Pharmaceutical Industry
Medicine Supply in CIS Countries: Discussion of the Model Law
Moderator: AREVIK MARKARYAN
Head of Strategic Sectors Department, Ministry of Economy of the Republic of Armenia
ELENA MAKSIMKINA
Director, Federal Center for Planning and Organization of Drug Provision for Citizens of the Ministry of Health of the Russian Federation
MARAT KALIYEV
International Expert, State Medical Insurance Fund of the Republic of Uzbekistan
RAFIK KHUDAYEV
Deputy Director General, Analytical Expertise Center of the Ministry of Health of the Republic of Azerbaijan
ASEL ESENALIEVA
Head of the Department of Drug Expertise, Department of Drugs and Medical Devices, Ministry of Health of the Kyrgyz Republic
ULDAN DERBISBEKOVA
Head of the Department of Drug Expertise, National Center for Drug and Medical Device Expertise
12:20 – 13:00
12:20 – 13:00
Coffee Break & Networking
13:00 – 14:20
13:00 – 14:20
Panel Session. Medicine Registration in the Eurasian Region
Unification of Registration Rules in the EAEU: Progress and Remaining Barriers
Uzbekistan's Experience in Aligning with EAEU Norms
Simplified Procedures for Innovative and Orphan Drugs
Pharmacopoeial Standards: Current Changes and Impact on Quality
Reducing Registration Timelines Through Unified Standards
The Impact of Regulatory Changes on Supply Chains
Moderator: LARISA MATVEEVA
Executive Director, Association of International Pharmaceutical Manufacturers
ELENA KOVALEVA
Director of the Center for Drug Quality Expertise, Scientific Center for Expertise of Medical Products of the Ministry of Health of the Russian Federation
AZER HASANOV
Head of the Department of Drug Registration and Expertise, Analytical Expertise Center of the Ministry of Health of the Republic of Azerbaijan
SAADAT SAGYNDYKOVA
Head of the EAEU Sector of the Department of Medicines and Medical Devices, Ministry of Health of the Kyrgyz Republic
TATIANA VASILYEVA
Head of Registration, Kazakhstan, AstraZeneca
ARDAK TULEGENOVA
Chairman, EAEU Pharmacopoeia Committee
ULDAN DERBISBEKOVA
Head of the Department of Drug Expertise, National Center for Drug and Medical Device Expertise
14:20 – 15:20
14:20 – 15:20
Lunch Break
15:20 – 16:40
15:20 – 16:40
Panel Session. Pricing and Economic Efficiency in the Pharmaceutical Industry
Comparison of Pricing Models in the EAEU and CIS
Financing High-Cost Therapy: Mechanisms and Challenges
Reference Pricing: Country Selection and Complexities
Opportunities for a Unified Pricing Mechanism in the EAEU
Balancing the Interests of Patients, the State, and Business
Moderator: VYACHESLAV LOKSHIN
President, Association of International Pharmaceutical Manufacturers in the Republic of Kazakhstan
TIMUR OTARSHINOV
Deputy Director of the Social Sector Department, Agency for Protection and Development of Competition of the Republic of Kazakhstan
ZAFAR VAKHIDOV
Partner, Vakhidov & Partners
ANASTASIIA KINGSHOTT
Head of Department for Health Technology Assessment, Center for Healthcare Quality Assessment and Control of the Ministry of Health of the Russian Federation
VICTORIA VYUSHKOVA
Head of CIS, Astellas
ANDREY IVANOV
Head of Market Access Department, Kazakhstan, AstraZeneca
ANDREY KOLESNIKOV
Sr. Director of External Communications, Government Affairs & Market Access, Russia and Eurasia, Teva
16:40 – 17:10
16:40 – 17:10
Coffee Break & Networking
17:10 – 18:30
17:10 – 18:30
Panel Session. Modern Models of Intellectual Property Protection and Management in the Pharmaceutical Industry
Patent Protection Strategies and Early Generic Entry
Data Exclusivity
Compulsory Licensing and Legal Disputes in the EAEU
Specifics of Patenting Innovative Drugs
Parallel Import: Risks and Opportunities
Combating Counterfeits and Copies
Certificates of State Registration (CSR) for Dietary Supplements
Moderator: VADIM KUKAVA
Executive Director, Association of Pharmaceutical Companies "Pharmaceutical Innovations" ("InPharma")
OLZHAS SATYBALDIN
Head of Government Relations, Russia and Eurasia, AstraZeneca
ALEXEY KARTASHOV
Director for Public Relations, HimRar Group
ALEXANDER CHERNICHENKO
General Director, Muse Media
ARTEM EZHOV
Chief Expert of the Chemistry and Medicine Department of the Expertise Administration, Eurasian Patent Organization
AZAMAT HAMRAKULOV
Deputy Head of the Samarkand Territorial Department, Committee for Competition Development and Consumer Protection of the Republic of Uzbekistan
RAVIL KASSILGOV
Managing Partner, KP Disputes
YERZHAN ZHUNISOV
Deputy Director, QAZPATENT
18:30
18:30
End of Day 1. Evening Reception and Informal Networking
Day 2, January 28
08:30 – 09:00
08:30 – 09:00
Morning Coffee & Networking
09:00 – 10:20
09:00 – 10:20
Expert Analytical Panel. Analysis of the EAEU Pharmaceutical Market: Key Trends, Challenges, and Growth Points
Sales Volumes and Segment Share (Generics, Innovative Drugs, and Biologics)
Market Growth Forecasts until 2027
Comparison with Global Trends
Impact of Inflation and Exchange Rate Fluctuations
Transformation of Consumer Preferences
Pharma Business Prospects for the Next 10 Years
Moderator: EKATERINA MARKOVA
Director, Proxima Research Kazakhstan
TIMUR OTARSHINOV
Deputy Director of the Social Sector Department, Agency for Protection and Development of Competition of the Republic of Kazakhstan
EVGENIY ZEMLYANKIN
General Director, Amity International
NURZHAN OTARBAYEV
Chairman of the National Chamber of Health and the Committee on Pharmaceutical, Medical Industry, and Medical Services of Atameken
ZHIBEK KERIMBAYEVA
Country Head Kazakhstan & Eurasia, IQVIA
ELENA KORHOVA
Deputy Director for Commercial Affairs, Polmed
ANDREY KONOVALOV
General Director, ratiopharm Kazakhstan
10:20 – 10:50
10:20 – 10:50
Coffee Break & Networking
10:50 – 12:10
10:50 – 12:10
Panel Session. National Pharmaceutical R&D Projects: Integrating Science, Production, and International Partnership
Search for New Molecules, Localization of Biopharmaceutical Production
Government Support: Funding, Certification, Procurement
Successful International Partnerships
Talent Retention and Development of Scientific Infrastructure
National Drug Security
Accelerated Scaling of Laboratory Technologies
Moderator: VITALII GORDIIENKO
Regional Director, Sona-Pharm
HANNA KARPENKA
Head of Scientific Affairs, Innowise
SHAHBALA YAGUBOV
Head of the Pharmaceuticals and Medical Equipment Department, Ministry of Health of the Republic of Azerbaijan
MONIKA BOZYCZKO
Business Development & Strategic Partnerships Manager, Business Development EMEA, Sartorius Stedim Biotech
12:10 – 12:40
12:10 – 12:40
Coffee Break & Networking
12:40 - 14:00
12:40 - 14:00
Panel Session. Commercialization of Pharmaceutical Products: Marketing and Digital Technologies
Online-Offline Integration in Marketing
Big Data and AI for Personalizing Communications
Digital Promotion Channels (E-commerce, Social Media, Mobile Apps)
Advertising Restrictions and Handling Personal Data
Sales Automation via CRM and Medical Representatives
Personalizing Interaction with Doctors and Pharmacies
Moderator: MARINA DURMANOVA
President, Association for the Support and Development of Pharmaceutical Activities of the Republic of Kazakhstan
LARISSA YEMELYANOVA
Partner, AEQUITAS Law Firm
ZHANNA KUNEKBAYEVA
General Director, Sona-Pharm Kazakhstan
ALEXANDER BEZBORODOV
Attorney-at-law, Partner, LL.M., ADVANT Beiten
IVAN MEDVEDEV
Executive Director, Apteka So Sklada
14:00 - 15:00
14:00 - 15:00
Lunch Break
15:00 - 16:20
15:00 - 16:20
Panel Session. From Plant to Patient: Optimizing Pharmaceutical Product Supply in the New Reality
Transport Corridors and Logistics Solutions
Cold Chains and Customs Clearance
Problems and Solutions in Implementing Track & Trace
Digital Order Management Platforms
Interaction Between Manufacturers, Distributors, and Pharmacies
Combating Counterfeits Through Supply Chain Transparency
Moderator: AIZHAN ZHAKSYGALIEVA
Head of the Distribution Quality Assurance Department, Medservice Plus
ALEXANDRA TIKHONOVA
Head of Projects, Department of Socially Significant Goods, Center for the Development of Advanced Technologies
EDUARD MURAKHOVSKIY
CIO of SKOPINPHARM, member of Russian Federation Government Expert Council, member of Russian Presidential Academy Talent Pool for digital transformation of public administration
RUSLAN ABSALYAMOV
Head of the Department of Product Labeling Control, Tax Committee of the Republic of Uzbekistan
KARINA KOLOBOVA
Advisor, VERBA LEGAL
EKATERINA TRETYAKOVA
Advisor, VERBA LEGAL
16:20 - 16:50
16:20 - 16:50
Coffee Break & Networking
16:50 – 18:00
16:50 – 18:00
Parallel sessions
Hall 1
How to Successfully Conduct Clinical Trials in EAEU Countries
Legislative Changes and National Requirements (borders with medicines)
Interaction with Medical Centers and Risk Management
Using AI in Data Analysis
GCP Inspections and Good Clinical Practice
Logistics of Clinical Trials
Labeling and Information Transparency
Moderator: SERGEY SAVASHINSKIY CEO, Eurasian Cooperation for Clinical Guidelines and Public Health Development (ECHD)
EKATERINA SOROKINA Director, Statandocs
MARIA LEER Clinical Quality Director, AstraZeneca
VITALY ZVEREV Scientific Director of the I.I. Mechnikov Scientific Research Institute of Vaccines and Serums, Head of the Department of Microbiology, Virology and Immunology. Academician A.I. Vorobyov of the F.F. Institute of Public Health. Erisman of the Sechenov First Moscow State Medical University, Academician of the Russian Academy of Sciences (online)
DZHULYETTA EKSUZYAN Regulatory Affairs and Quality Director, Russia & CIS, expert, Association of International Pharmaceutical Manufacturers
DAMILA NARTBAEVA Director, GCP WAY
MARGARITA GRAF Head of Clinical Trials Development Center, Salidat Kairbekova National Research Center for Health Development
Hall 2
The Dietary Supplements Market: New Consumer Trends and Growth Opportunities
Consumption Trends and Classification
Registration of Efficacy and Safety
Combating Falsification and the Uncontrolled Market
Growing Demand for Immunomodulators and Vitamins
Online Promotion Without Violations
Moderator: ALEXANDER ZHESTKOV Executive Director, Union of Dietary Supplement Manufacturers
NURKAN SADVAKASOV Deputy Chairman of the Committee for Sanitary and Epidemiological Control, Ministry of Healthcare of the Republic of Kazakhstan
ALEXANDER CHERNICHENKO General Director, Muse Media
LYUBOV ANDREEVA Head of the Sports Nutrition, Dietary Supplements, Technical Rehabilitation Equipment, and Wheelchairs Department, Center for the Development of Advanced Technologies
KARINA BULANOVA CEO, Zhiznivek
BAKHADIR AKHMETJANOV Regional Director, Central Asia & Caucasus, EAS Strategies
18:00
18:00
Summarizing and Closing of the Forum.
CONTaCT US
CONTaCT US
CONTaCT US
CONTaCT US
CONTaCT US
CONTaCT US
For any questions regarding participation, partnership, or registration, please reach out to our team: